Cargando…
Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
Prolactinoma has the highest incidence rate among patients with functional pituitary tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical, radiological and pathology features have been associated with a poor prognostic. Therefore, it can be considered as a group...
Autores principales: | Biagetti, Betina, Simò, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538771/ https://www.ncbi.nlm.nih.gov/pubmed/34681905 http://dx.doi.org/10.3390/ijms222011247 |
Ejemplares similares
-
Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms
por: Biagetti, Betina, et al.
Publicado: (2022) -
GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice
por: Biagetti, Betina, et al.
Publicado: (2021) -
Treatment of Prolactinoma
por: Inder, Warrick J., et al.
Publicado: (2022) -
Identification of driver genes and key pathways of prolactinoma predicts the therapeutic effect of genipin
por: Zhong, Sheng, et al.
Publicado: (2019) -
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
por: De Sousa, Sunita M C
Publicado: (2022)